(Q45094979)

9 December 2017

title

High risk of peripheral arterial disease in the United Kingdom: 2-year results of a prospective registry (English)

1 reference

9 December 2017

1 reference

1

Gerard Stansby

1 reference

9 December 2017

Rebecca Mister

2

1 reference

9 December 2017

Gerry Fowkes

3

1 reference

9 December 2017

Michael Roughton

4

1 reference

9 December 2017

Fiona Nugara

5

1 reference

9 December 2017

Julie Brittenden

6

1 reference

9 December 2017

Andrew Bradbury

7

1 reference

9 December 2017

Simon Ashley

8

1 reference

9 December 2017

Cliff Shearman

9

1 reference

9 December 2017

Ray Hannon

10

1 reference

9 December 2017

Marcus Flather

11

1 reference

9 December 2017

Prospective Registry and Evaluation of Peripheral Arterial Risks, Events and Distribution Investigators

12

1 reference

9 December 2017

publication date

1 February 2011

1 reference

9 December 2017

1 reference

9 December 2017

volume

62

1 reference

9 December 2017

issue

2

1 reference

9 December 2017

page(s)

111-118

1 reference

Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Efficient experimental design for binary matched pairs data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Vascular protection in peripheral artery disease: systematic review and modelling study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

The benefit of statins in non-cardiac vascular surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Medical treatment of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Better blood pressure control: how to combine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

The course of vascular risk factors and the occurrence of vascular events in patients with symptomatic peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Estimated glomerular filtration rate (eGFR) as a predictor of outcome after infrainguinal bypass in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Intermittent claudication. Incidence in the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Smoking behaviour in European patients with established coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Smoking cessation in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Life-style modification in peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

One-year cardiovascular event rates in outpatients with atherothrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Identification and management of polyvascular disease in patients with noncardioembolic ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Critical issues in peripheral arterial disease detection and management: a call to action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

Peripheral arterial disease: still on the periphery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319710387917

21 January 2018

Identifiers

DOI

10.1177/0003319710387917

1 reference

9 December 2017

1 reference